PATENT CLAIM ANALYSIS

Application Number: 16037726
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure provides expression vectors comprising at least two nucleic acid sequences, namely a nucleic acid sequence encoding an anti-HPRT RNAi, and a nucleic acid sequence encoding a gamma globin gene. In some embodiments, the viral vector is a self-inactivating lentiviral vector. In some embodiments, the gamma-globin gene is used to genetically correct sickle cell disease or β-thalassemia or to reduce symptoms thereof.

Claim (Index 12):
The vector of  claim 9 , wherein the 7sk promoter has the sequence of SEQ ID NO: 33.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 95.0
- Lexical Diversity: 1.47917
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13996984', '13504614', '15549895', '11660937', '15482284']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610142186327454
- 35 USC 102 Novelty (BERT): 0.5311659549345166
- Combined Prediction Score: 0.7380293922629226
- Mean Citation Score: 319.021612
- Max Citation Score: 325.36984
- Similarity Product: 223.98189256385805

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test